What are the treatment options for cystitis in men and women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cystitis in Men and Women

First-line treatment for uncomplicated cystitis is trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 3 days, but only when local resistance rates are below 20% and the patient has no history of recent TMP-SMX use or international travel. 1

First-Line Treatment Options

For uncomplicated cystitis, the Infectious Diseases Society of America (IDSA) and European Society for Microbiology and Infectious Diseases recommend:

  • Trimethoprim-sulfamethoxazole: 160/800 mg (1 double-strength tablet) twice daily for 3 days 1, 2
  • Nitrofurantoin monohydrate/macrocrystals: 100 mg twice daily for 5 days 1
  • Fosfomycin trometamol: 3 g single dose 1
  • Trimethoprim: 100 mg twice daily for 3 days 1

Treatment Selection Algorithm

  1. Check local resistance patterns:

    • If E. coli resistance to TMP-SMX is <20%: Use TMP-SMX as first-line
    • If resistance is >20% or patient has risk factors for resistance: Use alternative agents
  2. Consider patient-specific factors:

    • Renal function: Avoid nitrofurantoin if GFR <30 ml/min 1
    • Pregnancy status: Nitrofurantoin 100 mg twice daily for 5-7 days is appropriate, but avoid in third trimester 1
    • Diabetes: Requires special attention due to higher risk of complications 1
  3. For fluoroquinolones (e.g., ciprofloxacin):

    • Reserve as alternative options due to risk of adverse effects
    • Ciprofloxacin is FDA-approved for UTIs caused by susceptible strains 3
    • Should not be first-line due to concerns about promoting resistance

Special Populations

Men with Cystitis

  • Longer treatment duration typically required (7-14 days)
  • Consider evaluation for underlying structural abnormalities
  • For chronic bacterial prostatitis: Ciprofloxacin is indicated for infections caused by E. coli or Proteus mirabilis 3

Pregnant Women

  • Nitrofurantoin 100 mg twice daily for 5-7 days (avoid in third trimester)
  • Avoid TMP-SMX in first trimester (risk of neural tube defects) and third trimester (risk of kernicterus) 1

Patients with Diabetes

  • Ensure good glycemic control during treatment
  • May require longer treatment duration due to higher risk of complications 1

Patients with Renal Impairment

  • Avoid nitrofurantoin if GFR <30 ml/min
  • For hemodialysis patients: TMP-SMX at half the standard dose (one single-strength tablet daily or one double-strength tablet three times weekly) administered after each dialysis session 1

Treatment Duration

  • Uncomplicated cystitis: 3-5 days for most antibiotics (except fosfomycin: single dose) 1
  • Complicated cystitis: 5-7 days 1
  • Pyelonephritis: 10-14 days 1

Follow-up and Monitoring

  • Evaluate clinical response within 48-72 hours of initiating therapy 1
  • No routine follow-up urine culture needed in patients who respond to therapy 1
  • Follow-up urine culture should be performed 7 days after completing treatment in:
    • Pregnant women
    • Men
    • Patients with complicated infections
    • Those with persistent symptoms 1

Prevention of Recurrent Cystitis

For patients with recurrent infections (≥3 episodes/year):

  • Antibiotic prophylaxis options:

    • Nitrofurantoin 50-100 mg daily
    • Trimethoprim 100 mg daily
    • Post-coital single dose when UTIs are related to sexual activity 1
  • Non-antibiotic alternatives:

    • Methenamine hippurate (1 g twice daily)
    • Cranberry products containing 36 mg proanthocyanidin
    • Increased water intake (additional 1.5L daily) 1
    • Avoid spermicides and diaphragms 1, 4

Common Pitfalls to Avoid

  • Treating asymptomatic bacteriuria: Increases antibiotic resistance without clinical benefit (except in pregnancy) 1
  • Prolonged treatment courses: Increases risk of side effects and resistance without improving outcomes 1
  • Not obtaining urine culture before treatment in complicated cases or recurrent infections 1
  • Using fluoroquinolones as first-line therapy: Should be reserved for cases where other options cannot be used 1
  • Ignoring local resistance patterns: TMP-SMX efficacy is significantly reduced when resistance exceeds 20% 1, 5

Remember that a 5-day course of nitrofurantoin has been shown to be equivalent clinically and microbiologically to a 3-day course of TMP-SMX and should be considered when TMP-SMX cannot be used due to resistance concerns 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.